National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer

Filter
Article

Search results

  • 2020

    The National Lung Matrix Trial of personalized therapy in lung cancer

    Middleton, G., Fletcher, P., Popat, S., Savage, J., Summers, Y., Greystoke, A., Gilligan, D., Cave, J., O’rourke, N., Brewster, A., Toy, E., Spicer, J., Jain, P., Dangoor, A., Mackean, M., Forster, M., Farley, A., Wherton, D., Mehmi, M., Sharpe, R., & 7 othersMills, T. C., Cerone, M. A., Yap, T. A., Watkins, T. B. K., Lim, E., Swanton, C. & Billingham, L., 30 Jul 2020, In: Nature. 583, 7818, p. 807-812 6 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    14 Citations (Scopus)
    451 Downloads (Pure)